Free Trial

Gerresheimer (ETR:GXI) Trading Down 0.5% - Time to Sell?

Gerresheimer logo with Medical background

Gerresheimer AG (ETR:GXI - Get Free Report)'s stock price fell 0.5% on Friday . The stock traded as low as €45.04 ($51.77) and last traded at €45.54 ($52.34). 123,598 shares were traded during mid-day trading, a decline of 12% from the average session volume of 140,925 shares. The stock had previously closed at €45.76 ($52.60).

Gerresheimer Stock Up 1.5%

The company has a market cap of $1.58 billion, a price-to-earnings ratio of 13.85, a P/E/G ratio of 0.82 and a beta of 0.94. The stock's 50-day moving average is €55.04 and its 200-day moving average is €66.22. The company has a current ratio of 0.80, a quick ratio of 0.40 and a debt-to-equity ratio of 87.94.

About Gerresheimer

(Get Free Report)

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.

Featured Articles

Should You Invest $1,000 in Gerresheimer Right Now?

Before you consider Gerresheimer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gerresheimer wasn't on the list.

While Gerresheimer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines